Marinus Pharma
Pharmaceutical ManufacturingPennsylvania, United States51-200 Employees
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders.
Insights
Strategic Mergers Marinus Pharmaceuticals recently merged with Immedica, expanding its footprint and capabilities in the pharmaceutical industry, creating opportunities for collaborative sales and distribution channels targeting broader markets.
Partnership Potential The company's exclusive licensing agreement with Ovid Therapeutics for ganaxolone in treating specific seizure disorders highlights ongoing collaborations that could lead to additional licensing or distribution partnerships.
Emerging Market Focus Marinus' partnership with Orion Corporation for European commercialization indicates potential in expanding sales efforts into international markets, especially within Europe for its seizure disorder therapeutics.
Funding & Growth With $60 million in funding and evidence of ongoing drug development, there are opportunities to engage with Marinus at various stages of clinical trials and product launches in its pipeline.
Legal & Regulatory Challenges Recent legal actions and lawsuits against Marinus suggest areas where targeted compliance and legal consulting could support the company in navigating regulatory hurdles and safeguarding its market expansion.
Similar companies to Marinus Pharma
Anavex Life Sciences
$10M$25MCTI BioPharma
$100M$250MZynerba Pharmaceuticals
$1M$10MIntra-Cellular Therapies
$500M$1BSage Therapeutics
$50M$100MOvid Therapeutics
$1M
Marinus Pharma Tech Stack
Marinus Pharma uses 8 technology products and services including Salesforce, MySQL, Microsoft PowerPoint, and more. Explore Marinus Pharma's tech stack below.
- SalesforceCustomer Relationship Management
- MySQLDatabase
- Microsoft PowerPointEditors
- Underscore.jsJavascript Libraries
- LightboxJavascript Libraries
- MicrosoftMiscellaneous
- MediaElement.jsVideo Players
- FacebookWidgets
Media & News
Marinus Pharma's Email Address Formats
Marinus Pharma uses at least 1 format(s):
| Marinus Pharma Email Formats | Percentage |
| FLast@marinuspharma.com | 95% |
| Last@marinuspharma.com | 3% |
| First.Last@marinuspharma.com | 1% |
| FMiddleLast@marinuspharma.com | 1% |
Frequently Asked Questions
Where is Marinus Pharma's headquarters located?
Marinus Pharma's main headquarters is located at 5 Matsonford Road Suite 500 Radnor, Pennsylvania 19087 United States. The company has employees across 3 continents, including North AmericaAsiaEurope. What is Marinus Pharma's phone number?
You can contact Marinus Pharma's main corporate office by phone at +1-484-801-****
What is Marinus Pharma's stock symbol?
Marinus Pharma is a publicly traded company; the company's stock symbol is MRNS. What is Marinus Pharma's official website and social media links?
Marinus Pharma's official website is marinuspharma.com and has social profiles on LinkedIn.What is Marinus Pharma's SIC code NAICS code?
Marinus Pharma's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.How many employees does Marinus Pharma have currently?
As of February 2026, Marinus Pharma has approximately 51 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Chemistry, Manufacturing And Controls Officer: D. C.Chief Medical Officer: L. M.Chief Scientist: T. T.. Explore Marinus Pharma's employee directory with LeadIQ.What industry does Marinus Pharma belong to?
Marinus Pharma operates in the Pharmaceutical Manufacturing industry. What technology does Marinus Pharma use?
Marinus Pharma's tech stack includes SalesforceMySQLMicrosoft PowerPointUnderscore.jsLightboxMicrosoftMediaElement.jsFacebook. What is Marinus Pharma's email format?
Marinus Pharma's email format typically follows the pattern of FLast@marinuspharma.com. Find more Marinus Pharma email formats with LeadIQ. How much funding has Marinus Pharma raised to date?
As of February 2026, Marinus Pharma has raised $60M in funding. The last funding round occurred on Nov 07, 2022 for $60M.
Company Overview
- Headquarters
- 5 Matsonford Road Suite 500 Radnor, Pennsylvania 19087 United States
- Phone number
- +1-484-801-****
- Website
- marinuspharma.com
- SIC Code
- 2835 - In Vitro and In Vivo Diagnostic Substances
- Stock Symbol
- MRNS
- NAICS Code
- 3254 - Pharmaceutical and Medicine Manufacturing
- Employees
- 51-200
Media & News
Funding & Financials
- $60M
Marinus Pharma has raised a total of $60M of funding over 13 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $60M.
- $25M$50M
Marinus Pharma's revenue is estimated to be in the range of $25M$50M
Funding & Financials
- $60M
Marinus Pharma has raised a total of $60M of funding over 13 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $60M.
- $25M$50M
Marinus Pharma's revenue is estimated to be in the range of $25M$50M
Company Leadership
D. C.Chief Chemistry, Manufacturing And Controls Officer- L. M.Chief Medical Officer
T. T.Chief Scientist- G. L.Head Of Biometrics
- J. M.Head Of Market Access - Acute Care Franchise, Rare Disease
Employee Directory
- V. C.Executive Director, Corporate Compliance
- K. E.Senior Director, Market Access & Reimbursement
- E. A.Senior Director Regulatory Affairs
J. W.Senior Director- K. B.Associate Director
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
